LD-2 disclosure · 4th Quarter - Report
MERCK & CO. INC.
Client
- Name
- MERCK & CO. INC.
- Description
- Manufacturer of pharmaceuticals
- Location
- District of Columbia · United States of America
Registrant
- Description
- Consulting firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to supply chain and domestic manufacturing capacity.
LobbyistsMARY BETH SAVARY TAYLOR · GREG D'ANGELO · BRETT BAKER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · White House Office · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS) · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA)
Medicare/Medicaid
Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 946/S. 1862, ORPHAN Cures Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
LobbyistsMARY BETH SAVARY TAYLOR · GREG D'ANGELO · BRETT BAKER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · White House Office · Office of Management & Budget (OMB) · Centers For Medicare and Medicaid Services (CMS)
Taxation/Internal Revenue Code
Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.